Blog - Page 582 of 5695 - QualityStocks

MondayJan 08, 2024 3:40 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Joins CHFCA, Sets Completion Date for Non-Brokered Private Placement

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a leading green ammonia company, announced that it has joined the Canadian Hydrogen and Fuel Cell Association (“CHFCA”). “Farmers use 80% of the traditional, highly polluting, grey ammonia produced today, and ammonia is a critical chemical in many other sectors. The possibility of producing green ammonia on-site for nitrogen fertilizers, fuel-switching and water purification – with no carbon emissions – is drawing attention globally. It can replace the grey ammonia in virtually all the traditional sectors, significantly reducing carbon emissions worldwide,” said Nelson Leite, chief operating officer and board member of FuelPositive. “On-site green hydrogen…

MondayJan 08, 2024 3:26 pm

QualityStocksNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Announces Global Partnership in Expansion of Evolve(TM) Soft Bait to Open-Field Agriculture Applications

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations, has expanded the use of its innovative soft bait fertility control solution, Evolve(TM), into the open-field agriculture market. According to the announcement, this expansion includes a partnership with a global leader in irrigation solutions for sustainable agriculture; the first use of Evolve in the planned expansion will be at a California dairy and almond grower. Evolve focuses on the rapid reproduction of rats by reducing or eliminating the fertility of rats. Highly appealing to rats, Evolve is easy to deploy and can be used in many different environments; the…

MondayJan 08, 2024 3:15 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Unveils Ultimate Solution for Automotive Industry – Ultra

Cepton (NASDAQ: CPTN), a Silicon Valley innovator of high-performance lidar solutions, has announced the unveiling of its new flagship automotive lidar, Ultra. The world’s slimmest adaptive, long-range lidar, Ultra is designed based on real OEM requirements for next-generation consumer vehicle ADAS and automated driving capabilities. It boasts Cepton’s latest innovation – MagnoSteer(TM) – enabling an unmatched combination of performance, power efficiency and compactness. “Powered by MagnoSteer, Ultra breaks the performance bottleneck of 905 nm lidars while taking advantage of a mature, mass-market-ready laser technology. With a 300 m detection range at 10% reflectivity, it can detect and locate a dark…

MondayJan 08, 2024 2:59 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Submits Concept Paper to DOE for Domestic Battery Materials Processing

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that its subsidiary Mullen Advanced Energy, LLC submitted a Concept Paper in response to the U.S. Department of Energy (“DOE”) Funding Opportunity for Battery Materials. Established on Nov. 13, 2023, via the current administration, the program announces up to $3.5 billion from the Bipartisan Infrastructure Law to boost domestic production of advanced batteries and battery materials nationwide. Mullen’s submission details its plan to produce approximately 150,000 battery packs domestically through calendar year 2032 to support Mullen’s EVs, currently assembled in the U.S. at the Company’s Tunica, Mississippi-based plant.…

MondayJan 08, 2024 2:18 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Significant Positive Results from LTE VISIONARY-MS Trial

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including (“ALS”) and multiple sclerosis (“MS”), today reported new CNM-Au8(R) results from the long-term open label extension (“LTE”) of the VISIONARY-MS trial in participants with stable relapsing multiple sclerosis (“RMS”) totaling nearly three years of follow-up. After completion of the double-blind period, study participants were offered to continue on CNM-Au8 30mg for up to an additional 96-weeks in the LTE. Analyses were reported for the modified intent…

MondayJan 08, 2024 1:51 pm

QualityStocksNewsBreaks – Upstream Breaks Mold for Payment for Order Flow, Builds Transparent Trading Environment

Upstream, the revolutionary retail trading app for stocks and NFTs powered by Horizon Fintex and MERJ Exchange Limited, doesn’t require payment for order flow (“PFOF”). Upstream’s smart-contract-powered market avoids it, an example of the app’s commitment to build a transparent trading environment. According to a recent blog published on Medium, PFOF is a “form of compensation, usually in terms of fractions of a penny per share, that a brokerage firm receives for directing orders for trade execution to a particular market maker or exchange.” The blog explains that investors trading through online brokerage accounts sometimes think they have a direct…

MondayJan 08, 2024 11:15 am

Astrotech Corp. (NASDAQ: ASTC) Announces New Mass Spectrometry Technology Application for Chemical Manufacturing and Introduces the Pro-Control Subsidiary

Astrotech’s newest subsidiary, Pro-Control, will use the company’s mass spectrometer technology to improve purity, and yields of distilled chemicals Pro-Control delivers value by improving lost yields and delivering found profits directly to the bottom line with little, which the company believes will lead to an overall increase in profitability Astrotech believes that the Pro-Control MVP has the ability to routinely improve yields from 20% to 30% The company is introducing its proprietary ATi Mass Spectrometer Technology into the vast chemical manufacturing and process control markets Astrotech (NASDAQ: ASTC), is an instrumentation company that is focused on commercializing its proprietary ATi…

MondayJan 08, 2024 10:30 am

Correlate Energy Corp. (CIPI) Marks Successful Close to the Year with Commissioning of ATD’s Huntersville Headquarters Solar Project

Correlate Energy, a distributed energy solutions company, just announced the successful commissioning of another solar project, this one located in ATD’s Huntersville headquarters The anticipated benefits for ATD go beyond environmental gains and into the expected generation of substantial cost savings by reducing reliance on traditional energy sources ATD’s solar power project follows Continental Envelope’s rooftop solar installation announced earlier Correlate Energy (OTCQB: CIPI), successfully capitalizing on the continued corporate push for financially positive decentralized energy generation, just announced the successful commissioning a major solar project located in American Tire Distributors’ (“ATD”) Huntersville, North Carolina headquarters. This follows the successful…

MondayJan 08, 2024 9:45 am

Turbo Energy (NASDAQ: TURB) Strategically Positioned for Growth in the Age of Artificial Intelligence

Despite challenges in the self-consumption photovoltaic sector, Turbo Energy achieved remarkable milestones, including the launch of the SunBox Industry product line, securing a patent, and forming strategic partnerships The company raised $5 million through its American Depositary Shares on the Nasdaq Capital Market, demonstrating its financial prowess amid industry headwinds Despite industry challenges, Turbo Energy maintains an optimistic outlook, leveraging diverse product offerings based on AI-driven energy optimization In the midst of challenges faced by the self-consumption photovoltaic sector in 2023, Turbo Energy (NASDAQ: TURB), a Spain-based photovoltaic energy storage innovator, achieved notable achievements. Despite revenue decline due to headwinds…

MondayJan 08, 2024 9:00 am

Sigyn Therapeutics Inc. (SIGY) Is ‘One to Watch’

Sigyn Therapeutics in May 2023 announced patent and trademark applications for its ImmunePrep commercialization platform In October 2022, the company announced patent and trademark applications for ChemoPrep and ChemoPure to enhance chemotherapy and reduce toxicity Sigyn Therapeutics in September 2022 announced plans to conduct first-in-human feasibility studies in end-stage renal disease patients In August 2022, the company commenced trading on the OTCQB Venture Market Sigyn Therapeutics (OTCQB: SIGY) is a development-stage medical technology company headquartered in San Diego, California. The company’s therapeutic candidates include Sigyn Therapy(TM) to address pathogen-associated inflammatory disorders, the ImmunePrep(TM) platform to enhance the performance of immunotherapeutic…

Site Search

Company Search